← Back to Search

Coin2Dose for Type 1 Diabetes (Coin2Dose Trial)

N/A
Recruiting
Research Sponsored by Nemours Children's Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Adolescents with a physician confirmed diagnosis of type 1 diabetes of at least 6 months duration
Adolescents who use an insulin pump for daily type 1 diabetes self-management
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change in week 0 outcome at week 13
Awards & highlights

Coin2Dose Trial Summary

This trial aims to see if incentives can help teens with diabetes use insulin better, using semi-automated tech.

Who is the study for?
This trial is for English-speaking teens aged 11-17 with Type 1 Diabetes who use an insulin pump but have a low daily BOLUS score, indicating they're not using enough insulin. They must be diagnosed for at least 6 months. Teens with allergies to CGM adhesives or other chronic conditions like renal disease can't join.Check my eligibility
What is being tested?
The Coin2Dose program uses behavioral economics incentives to encourage teens with Type 1 Diabetes to increase their daily insulin BOLUS usage. The study will assess if this approach is practical, acceptable, and effective in improving diabetes management.See study design
What are the potential side effects?
Since the intervention involves behavioral incentives rather than medication, traditional side effects are not expected. However, there may be psychological impacts from participating in the incentive program that will be monitored.

Coin2Dose Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with type 1 diabetes for at least 6 months.
Select...
I use an insulin pump for my type 1 diabetes.
Select...
I am between 11 and 17 years old, or I am the parent/guardian of someone who is.

Coin2Dose Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change in week 0 outcome at week 13
This trial's timeline: 3 weeks for screening, Varies for treatment, and change in week 0 outcome at week 13 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Glucose time in range
Change in Glycated Hemoglobin- HbA1c
Change in daily insulin Bolus score

Coin2Dose Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Coin2DoseExperimental Treatment1 Intervention
BEI intervention that also combines automated text message reminders to dose for insulin; will test Contingent and Non-Contingent BEI
Group II: Standard Care ControlActive Control1 Intervention
Standard care control group; will not receive automated text message reminders to dose for insulin nor BEI for daily BOLUS scores

Find a Location

Who is running the clinical trial?

Nemours Children's ClinicLead Sponsor
124 Previous Clinical Trials
18,001 Total Patients Enrolled

Media Library

Coin2Dose Clinical Trial Eligibility Overview. Trial Name: NCT05280184 — N/A
Type 1 Diabetes Research Study Groups: Coin2Dose, Standard Care Control
Type 1 Diabetes Clinical Trial 2023: Coin2Dose Highlights & Side Effects. Trial Name: NCT05280184 — N/A
Coin2Dose 2023 Treatment Timeline for Medical Study. Trial Name: NCT05280184 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this research endeavor allow participants aged 18 and over?

"The criteria for being a part of this clinical trial states that the participant must be aged between 11 and 17."

Answered by AI

Is it possible to register for this study at the current time?

"This clinical trial is still accepting participants. It was first listed on the 1st of January 2023 and last amended on 28th February 2023 per information provided by clinicaltrials.gov."

Answered by AI

Am I eligible to participate in this scientific investigation?

"This trial is on the search for 150 juvenile individuals with type 1 diabetes, aged between 11 and 17 years. To be eligible to participate, adolescents must have a doctor-verified diagnosis of T1D lasting at least 6 months; they should use insulin pumps to manage their condition; and they need to demonstrate suboptimal daily BOLUS scores (a mean score lower than 2.5)."

Answered by AI

How many participants are currently involved in this research endeavor?

"Affirmative. The info hosted on clinicaltrials.gov reveals that this research, which was initially advertised on January 1st 2023, is still actively recruiting participants. 150 people are required to be enrolled from 2 medical centres."

Answered by AI
~69 spots leftby Mar 2025